{"data":[{"accessionNo":"0002100119-26-001413","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001367644","issuerName":"Emergent BioSolutions Inc","ticker":"EBS","cusip":"29089Q105","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":2540945,"percentOfClass":4.92,"filedAt":"2026-07-31","canonicalUrl":"https://xoomar.com/markets/stocks/ebs"},{"accessionNo":"0002012383-26-002482","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001367644","issuerName":"EMERGENT BIOSOLUTIONS INC","ticker":"EBS","cusip":"29089Q105","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":4651339,"percentOfClass":9,"filedAt":"2026-07-28","canonicalUrl":"https://xoomar.com/markets/stocks/ebs"},{"accessionNo":"0002100119-26-000472","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001367644","issuerName":"Emergent BioSolutions Inc","ticker":"EBS","cusip":"29089Q105","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":2605090,"percentOfClass":5.04,"filedAt":"2026-04-29","canonicalUrl":"https://xoomar.com/markets/stocks/ebs"},{"accessionNo":"0000354204-26-000520","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001367644","issuerName":"Emergent BioSolutions Inc","ticker":"EBS","cusip":"29089Q105","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Dimensional Fund Advisors LP","reportingCik":null,"personType":"IA","sharesOwned":2757158,"percentOfClass":5.3,"filedAt":"2026-04-09","canonicalUrl":"https://xoomar.com/markets/stocks/ebs"},{"accessionNo":"0000102909-26-001106","formType":"SCHEDULE 13G/A","amendmentNo":15,"issuerCik":"0001367644","issuerName":"Emergent BioSolutions Inc","ticker":"EBS","cusip":"29089Q105","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26","canonicalUrl":"https://xoomar.com/markets/stocks/ebs"},{"accessionNo":"0000093751-26-000044","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001367644","issuerName":"EMERGENT BIOSOLUTIONS INC","ticker":"EBS","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"STATE STREET CORPORATION","reportingCik":null,"personType":"HC","sharesOwned":2696375,"percentOfClass":5.1,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/ebs"},{"accessionNo":"0000102909-26-000130","formType":"SCHEDULE 13G/A","amendmentNo":14,"issuerCik":"0001367644","issuerName":"Emergent BioSolutions Inc","ticker":"EBS","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":3553999,"percentOfClass":6.76,"filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/ebs"}],"updatedAt":"2026-10-24T17:46:37.919Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/ebs","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}